Review



pgrna plasmid library  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Addgene inc pgrna plasmid library
    Pgrna Plasmid Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pgrna plasmid library/product/Addgene inc
    Average 90 stars, based on 10 article reviews
    pgrna plasmid library - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    98
    New England Biolabs bsmbi digested pgrna library plasmids
    Bsmbi Digested Pgrna Library Plasmids, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bsmbi digested pgrna library plasmids/product/New England Biolabs
    Average 98 stars, based on 1 article reviews
    bsmbi digested pgrna library plasmids - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    90
    Addgene inc pgrna plasmid library
    Pgrna Plasmid Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pgrna plasmid library/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    pgrna plasmid library - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    93
    Addgene inc blaer1 pgrna crispr library
    Cellular model and targets selection. A Transdifferentiation of <t>BLaER1</t> pre-B cells into macrophages is accompanied by a dynamic transcriptomic remodeling of the cells. BLaER1 lymphocytes transdifferentiate into functional macrophages in the presence of Interleukin 3 (IL-3) and Macrophage colony-stimulating factor (M-CSF) upon β-estradiol induced release of CEBPaER to the nucleus. B Flow cytometry analysis of cell surface markers at T0, T3 (3 days) and T6 (6 days) after induced transdifferentiation in the BLaER1-Cas9 cell line. During the process, BLaER1 cells progressively lose the CD19 (B-cell marker staining -X-axis-) and gain the Mac1 (macrophage marker staining -Y-axis-). C Merged k-means clustered expression profiles (color code) of peaking and upregulated genes during transdifferentiation: 16 initial clusters of lncRNA ( n = 174) and 36 initial clusters of protein coding genes ( n = 939). FPKM values were log10 transformed before the normalization to z-score. Each line shows the expression pattern of a gene along transdifferentiation. The color corresponds to the k-means cluster to which the gene belongs (see also Supplementary Fig. S and S )
    Blaer1 Pgrna Crispr Library, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/blaer1 pgrna crispr library/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    blaer1 pgrna crispr library - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    Cellular model and targets selection. A Transdifferentiation of BLaER1 pre-B cells into macrophages is accompanied by a dynamic transcriptomic remodeling of the cells. BLaER1 lymphocytes transdifferentiate into functional macrophages in the presence of Interleukin 3 (IL-3) and Macrophage colony-stimulating factor (M-CSF) upon β-estradiol induced release of CEBPaER to the nucleus. B Flow cytometry analysis of cell surface markers at T0, T3 (3 days) and T6 (6 days) after induced transdifferentiation in the BLaER1-Cas9 cell line. During the process, BLaER1 cells progressively lose the CD19 (B-cell marker staining -X-axis-) and gain the Mac1 (macrophage marker staining -Y-axis-). C Merged k-means clustered expression profiles (color code) of peaking and upregulated genes during transdifferentiation: 16 initial clusters of lncRNA ( n = 174) and 36 initial clusters of protein coding genes ( n = 939). FPKM values were log10 transformed before the normalization to z-score. Each line shows the expression pattern of a gene along transdifferentiation. The color corresponds to the k-means cluster to which the gene belongs (see also Supplementary Fig. S and S )

    Journal: BMC Genomics

    Article Title: Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages

    doi: 10.1186/s12864-022-08612-7

    Figure Lengend Snippet: Cellular model and targets selection. A Transdifferentiation of BLaER1 pre-B cells into macrophages is accompanied by a dynamic transcriptomic remodeling of the cells. BLaER1 lymphocytes transdifferentiate into functional macrophages in the presence of Interleukin 3 (IL-3) and Macrophage colony-stimulating factor (M-CSF) upon β-estradiol induced release of CEBPaER to the nucleus. B Flow cytometry analysis of cell surface markers at T0, T3 (3 days) and T6 (6 days) after induced transdifferentiation in the BLaER1-Cas9 cell line. During the process, BLaER1 cells progressively lose the CD19 (B-cell marker staining -X-axis-) and gain the Mac1 (macrophage marker staining -Y-axis-). C Merged k-means clustered expression profiles (color code) of peaking and upregulated genes during transdifferentiation: 16 initial clusters of lncRNA ( n = 174) and 36 initial clusters of protein coding genes ( n = 939). FPKM values were log10 transformed before the normalization to z-score. Each line shows the expression pattern of a gene along transdifferentiation. The color corresponds to the k-means cluster to which the gene belongs (see also Supplementary Fig. S and S )

    Article Snippet: The library is available at Addgene.org (BLaER1 pgRNA CRISPR library ID 183825).

    Techniques: Selection, Functional Assay, Flow Cytometry, Marker, Staining, Expressing, Transformation Assay

    pgRNA CRISPR library for lncRNA and pc-genes. A (Upper panel) Diagram of the CD19 gene indicating the target sequence of CD19 pgRNAs (sgRNA1 and sgRNA2, from left to right). (Lower panel) Flow cytometry analysis of fluorescence intensity of the CD19 protein in BLaER1-Cas9 cells infected with sgRNAs and pgRNAs. The relative Stain Index of the different infected cells compared to the maximum expression level of CD19 in control cells (BLaER1-Cas9 cells infected with pDECKO-GFP ) is represented. CD19 expression is reduced between 30 and 95% upon infection of sgRNAs. The infection of pgRNAs induces a consistent reduction of CD19 signal up to 95% with all pgRNAs tested. B Schematic diagram showing the position of pgRNAs targeting lncRNAs (targeting the promoter and the transcription start site) and pc-genes (targeting coding exons). C CRISPR library composition (number of targets of each biotype and pgRNA pairs designed per target)

    Journal: BMC Genomics

    Article Title: Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages

    doi: 10.1186/s12864-022-08612-7

    Figure Lengend Snippet: pgRNA CRISPR library for lncRNA and pc-genes. A (Upper panel) Diagram of the CD19 gene indicating the target sequence of CD19 pgRNAs (sgRNA1 and sgRNA2, from left to right). (Lower panel) Flow cytometry analysis of fluorescence intensity of the CD19 protein in BLaER1-Cas9 cells infected with sgRNAs and pgRNAs. The relative Stain Index of the different infected cells compared to the maximum expression level of CD19 in control cells (BLaER1-Cas9 cells infected with pDECKO-GFP ) is represented. CD19 expression is reduced between 30 and 95% upon infection of sgRNAs. The infection of pgRNAs induces a consistent reduction of CD19 signal up to 95% with all pgRNAs tested. B Schematic diagram showing the position of pgRNAs targeting lncRNAs (targeting the promoter and the transcription start site) and pc-genes (targeting coding exons). C CRISPR library composition (number of targets of each biotype and pgRNA pairs designed per target)

    Article Snippet: The library is available at Addgene.org (BLaER1 pgRNA CRISPR library ID 183825).

    Techniques: CRISPR, Sequencing, Flow Cytometry, Fluorescence, Infection, Staining, Expressing

    CRISPR-Cas9 screening in BLaER cells . A Workflow of the CRISPR screening experiment. The pDECKO plasmid library was transfected into HeK293T cells to obtain a library of lentivirus. BLaER1-Cas9 cells were infected at a low multiplicity of infection and double selected with antibiotics (Blasticidin and Puromycin) for 20 days. The infected cells were induced for transdifferentiation into macrophages for 3 days (T3) and 6 days (T6). Cells were labeled with antibodies against cell surface markers: CD19 (for B-lymphocytes) and Mac1 (for macrophages). Transdifferentiation status was assessed by flow cytometry. Transdifferentiated and delayed populations were isolated by Fluorescence-Activated Cell Sorting (FACS). B Flow cytometry analysis of BLaER1-Cas9 cells infected with the pDECKO_non-targeting control (left panels) and with the pDECKO_CRISPR-library (right panels) at T0, T3 and T6 of transdifferentiation. CD19 antibody, conjugated with BV510 fluorophore, was used to identify B-cells and Mac1 antibody, conjugated with PE-Cy7 fluorophore, was used to identify macrophages. Quadrants are as follows: Q1 (macrophage-like cells with presence of Mac1 and absence of CD19 surface markers); Q2 (transition cells with the presence of Mac1 and CD19); Q3 (background and not stained cells, negative for Mac1 and CD19); Q4 (lymphocyte B-like cells with the presence of CD19 and absence of Mac1 surface markers). The percentage of cells in each of the 4 quadrants is shown. The fraction of sorted cells showing a delay of transdifferentiation (“delayed” fraction) is marked in blue (gate P4), and sorted cells that differentiate at a normal pace (“differentiated” fraction) are marked in orange (gate P5). See also Supplementary Fig. S . C Workflow for processing the sorted cell populations for deep sequencing. Genomic DNA of sorted cells was extracted and PCR amplified in two steps. For the first PCR, specific staggered primers were used to amplify the integrated fragment which contains the pgRNAs. For the second PCR, Illumina barcoded primers were used to pool different samples (see also Supplementary Fig. S ). Samples were sequenced by 150 bp paired-end Illumina sequencing. DDE (differentiation delayed effect) was calculated as the ratio of pgRNA counts in the delayed population versus the counts in the transdifferentiated population

    Journal: BMC Genomics

    Article Title: Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages

    doi: 10.1186/s12864-022-08612-7

    Figure Lengend Snippet: CRISPR-Cas9 screening in BLaER cells . A Workflow of the CRISPR screening experiment. The pDECKO plasmid library was transfected into HeK293T cells to obtain a library of lentivirus. BLaER1-Cas9 cells were infected at a low multiplicity of infection and double selected with antibiotics (Blasticidin and Puromycin) for 20 days. The infected cells were induced for transdifferentiation into macrophages for 3 days (T3) and 6 days (T6). Cells were labeled with antibodies against cell surface markers: CD19 (for B-lymphocytes) and Mac1 (for macrophages). Transdifferentiation status was assessed by flow cytometry. Transdifferentiated and delayed populations were isolated by Fluorescence-Activated Cell Sorting (FACS). B Flow cytometry analysis of BLaER1-Cas9 cells infected with the pDECKO_non-targeting control (left panels) and with the pDECKO_CRISPR-library (right panels) at T0, T3 and T6 of transdifferentiation. CD19 antibody, conjugated with BV510 fluorophore, was used to identify B-cells and Mac1 antibody, conjugated with PE-Cy7 fluorophore, was used to identify macrophages. Quadrants are as follows: Q1 (macrophage-like cells with presence of Mac1 and absence of CD19 surface markers); Q2 (transition cells with the presence of Mac1 and CD19); Q3 (background and not stained cells, negative for Mac1 and CD19); Q4 (lymphocyte B-like cells with the presence of CD19 and absence of Mac1 surface markers). The percentage of cells in each of the 4 quadrants is shown. The fraction of sorted cells showing a delay of transdifferentiation (“delayed” fraction) is marked in blue (gate P4), and sorted cells that differentiate at a normal pace (“differentiated” fraction) are marked in orange (gate P5). See also Supplementary Fig. S . C Workflow for processing the sorted cell populations for deep sequencing. Genomic DNA of sorted cells was extracted and PCR amplified in two steps. For the first PCR, specific staggered primers were used to amplify the integrated fragment which contains the pgRNAs. For the second PCR, Illumina barcoded primers were used to pool different samples (see also Supplementary Fig. S ). Samples were sequenced by 150 bp paired-end Illumina sequencing. DDE (differentiation delayed effect) was calculated as the ratio of pgRNA counts in the delayed population versus the counts in the transdifferentiated population

    Article Snippet: The library is available at Addgene.org (BLaER1 pgRNA CRISPR library ID 183825).

    Techniques: CRISPR, Plasmid Preparation, Transfection, Infection, Labeling, Flow Cytometry, Isolation, Fluorescence, FACS, Staining, Sequencing, Amplification

    FURIN and NFE2 expression after CRISPR edition. A FURIN RNA and protein expression. Cells were collected at T0 (before induction) and T3 (3 days after transdifferentiation induction). (CT0) and (CT3) negative control pDECKO-Intergenic at T0 and T3 respectively, (FUT0) and (FUT3) pDECKO-FURIN at T0 and T3, (FUT3s) pDECKO-FURIN at T3 and sorted from gate P4 (delayed population). Upper panel, qRT-PCR to check the expression of FURIN using two different sets of primers. Results are normalized to GAPDH and the fold change is calculated relative to the expression of cells infected with pDECKO-intergenic pgRNA at T3. The expression of FURIN decreases in cells infected with FURIN pgRNAs, especially in the delayed subpopulation (FUT3s). Bottom panel, western blot to assess the levels of the FURIN protein in BLaER1-Cas9 infected cells. Anti-FURIN antibodies recognize a band (marked with an arrowhead), the signal of which increases at T3, in line with RNA-Seq data (Supplementary Table S4). The FURIN band is not detectable in the pDECKO-FURIN infected cells (FUT3 and FUT3s). Uncropped blots are shown in Supplementary Fig. S A. B NFE2 RNA and protein expression. (CT0) and (CT2) negative control pDECKO-Intergenic at T0 (before induction) and T2 (2 days after transdifferentiation induction) respectively, (NFT0) and (NFT2) pDECKO-NFE2 at T0 and T2, (NFT2s) pDECKO-NFE2 at T2 and sorted from gate P4 (delayed population). Upper panel, qRT-PCR to check the expression of NFE2 using 2 different sets of primers. Results are normalized to GAPDH and the fold change is calculated relative to the expression of cells infected with pDECKO-intergenic T2. NFE2 expression in NFE2 pgRNA targeted cells is higher than in intergenic control cells (NFT2 and NFT2s compared to CT2). Bottom panel, western blot to check the protein levels of NFE2 in BLaER1-Cas9 infected cells. Anti-NFE2 antibodies detect two bands, the signal of which increases at T2 (CT2 compared to CT0). These two bands are strongly reduced in NFE2 targeted populations (NFT2 and NFT2s compared to CT2). Uncropped blots are shown in Supplementary Fig. S B

    Journal: BMC Genomics

    Article Title: Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages

    doi: 10.1186/s12864-022-08612-7

    Figure Lengend Snippet: FURIN and NFE2 expression after CRISPR edition. A FURIN RNA and protein expression. Cells were collected at T0 (before induction) and T3 (3 days after transdifferentiation induction). (CT0) and (CT3) negative control pDECKO-Intergenic at T0 and T3 respectively, (FUT0) and (FUT3) pDECKO-FURIN at T0 and T3, (FUT3s) pDECKO-FURIN at T3 and sorted from gate P4 (delayed population). Upper panel, qRT-PCR to check the expression of FURIN using two different sets of primers. Results are normalized to GAPDH and the fold change is calculated relative to the expression of cells infected with pDECKO-intergenic pgRNA at T3. The expression of FURIN decreases in cells infected with FURIN pgRNAs, especially in the delayed subpopulation (FUT3s). Bottom panel, western blot to assess the levels of the FURIN protein in BLaER1-Cas9 infected cells. Anti-FURIN antibodies recognize a band (marked with an arrowhead), the signal of which increases at T3, in line with RNA-Seq data (Supplementary Table S4). The FURIN band is not detectable in the pDECKO-FURIN infected cells (FUT3 and FUT3s). Uncropped blots are shown in Supplementary Fig. S A. B NFE2 RNA and protein expression. (CT0) and (CT2) negative control pDECKO-Intergenic at T0 (before induction) and T2 (2 days after transdifferentiation induction) respectively, (NFT0) and (NFT2) pDECKO-NFE2 at T0 and T2, (NFT2s) pDECKO-NFE2 at T2 and sorted from gate P4 (delayed population). Upper panel, qRT-PCR to check the expression of NFE2 using 2 different sets of primers. Results are normalized to GAPDH and the fold change is calculated relative to the expression of cells infected with pDECKO-intergenic T2. NFE2 expression in NFE2 pgRNA targeted cells is higher than in intergenic control cells (NFT2 and NFT2s compared to CT2). Bottom panel, western blot to check the protein levels of NFE2 in BLaER1-Cas9 infected cells. Anti-NFE2 antibodies detect two bands, the signal of which increases at T2 (CT2 compared to CT0). These two bands are strongly reduced in NFE2 targeted populations (NFT2 and NFT2s compared to CT2). Uncropped blots are shown in Supplementary Fig. S B

    Article Snippet: The library is available at Addgene.org (BLaER1 pgRNA CRISPR library ID 183825).

    Techniques: Expressing, CRISPR, Negative Control, Quantitative RT-PCR, Infection, Western Blot, RNA Sequencing Assay